Skip to content

The Effect of Motilin on the Frequency and Amount of Food Intake

Influence of Erythromycin on ad Libitum Food Intake and the Evaluation of Motilin in Food Timing in Healthy Volunteers and Patients

Status
Enrolling by invitation
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03024879
Enrollment
15
Registered
2017-01-19
Start date
2014-03-31
Completion date
2025-03-31
Last updated
2024-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy, Obesity

Keywords

Motilin, Erythromycin, Food intake

Brief summary

In this study, the investigators aimed at evaluating the role of motilin in the regulation of food intake. Motilin, a gastrointestinal hormone, is a hunger signal in healthy volunteers and is significantly increased in obese patients. Its role in food intake regulation might contribute to the pathogenesis of obesity.

Interventions

DRUGErythromycin
DRUGSaline

Sponsors

Universitaire Ziekenhuizen KU Leuven
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI \< 30 kg/m² for lean volunteers * BMI \> 30 kg/m² for obese volunteers * Subject is capable and willing to give informed consent * Female volunteers of child bearing potential must use oral, injected or implanted hormonal methods of contraception

Exclusion criteria

* Female volunteer is pregnant or breastfeeding * GI diseases, major abdominal surgery * Major psychiatric illnesses * Volunteers that use drugs affecting the GI tract or the central nervous system * Volunteers suffering from endocrine diseases such as diabetes, Cushing's disease, Addison's disease, hypothalamic tumor * Volunteers that have undergone surgical procedure for weight loss

Design outcomes

Primary

MeasureTime frame
Change in food intake, assessed by caloric intake, after intravenous administration of erythromycin compared to placeboCaloric intake will be assessed 1 hour after the start of infusion and the start of ad libitum food intake

Secondary

MeasureTime frame
Frequency of food intake correlated with motilin plasma levelsAssessment will be done over a period of 5 hours

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026